The activation of FXR by BAs induced the expression of intestinal fibroblast growth factor (FGF) 15/19, which has been shown to regulate skeletal muscle mass and ameliorate obesity-induced muscle atrophy (Benoit et al., 2017). Here, NR1H4 is linked to obesity disorder.